Sign In
Buy JNJ
$239.08
+7.79 (+3.37%)
At Close: Jun 23, 2026
Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know
10:45pm, Wednesday, 30'th Nov 2022 Zacks Investment Research
Johnson & Johnson (JNJ) closed at $178 in the latest trading session, marking a +1.08% move from the prior day.
S&P 500's Best Dividend Aristocrats
10:04pm, Wednesday, 30'th Nov 2022 The Motley Fool
Investors looking for stability and payout growth should look closer at Dividend Aristocrat stocks.
Analyst Forecasts $101-117/Share Offer Price For Horizon Therapeutics' Buyout
06:52pm, Wednesday, 30'th Nov 2022 Benzinga
Horizon Therapeutics Plc (NASDAQ: HZNP) confirmed it's engaged in preliminary talks with Amgen Inc (NASDAQ: AMGN), Janssen Global Service, and Sanofi SA SNY on potential takeover offers for th
Gurus Prescribed These Health Care Stocks in the 3rd Quarter
05:31pm, Wednesday, 30'th Nov 2022
Amid rising concerns about the state of the global economy, rising inflation, central bank interest rate hikes and increased Covid-19 restrictions in China, marked indexes were mixed on Wednesday morn
Horizon (HZNP) Up on Initial Talks of Buyout by Pharma Giants
04:49pm, Wednesday, 30'th Nov 2022 Zacks Investment Research
Horizon (HZNP) holds preliminary discussions with Amgen, Sanofi and Janssen, a subsidiary of J&J, seeking an offer for its acquisition by any one of the pharma giants. Shares rise.
Why Horizon Therapeutics Stock Is Skyrocketing Today
04:15pm, Wednesday, 30'th Nov 2022 The Motley Fool
Three big drugmakers could be interested in acquiring Horizon.
Banks are short more than $1 trillion in capital, says this analyst, who fears the shortfall will only get worse
01:37pm, Wednesday, 30'th Nov 2022 MarketWatch
If bank assets are marked to market, the U.S. sector is insolvent, according to an independent analyst.
3 Top Dividend Kings to Buy for the Long Haul
01:05pm, Wednesday, 30'th Nov 2022 The Motley Fool
Dividend stocks are an easy option to boost income.
Is iShares Core High Dividend ETF (HDV) a Strong ETF Right Now?
11:20am, Wednesday, 30'th Nov 2022 Zacks Investment Research
Smart Beta ETF report for HDV
Should Vanguard Value ETF (VTV) Be on Your Investing Radar?
11:20am, Wednesday, 30'th Nov 2022 Zacks Investment Research
Style Box ETF report for VTV
3 Warren Buffett Stocks to Buy Hand Over Fist Before 2023
11:00am, Wednesday, 30'th Nov 2022 The Motley Fool
These stocks could grow Buffett's wealth -- and yours.
Horizon Therapeutics in preliminary sale talks with Amgen, Sanofi, J&J
10:37am, Wednesday, 30'th Nov 2022
CNBC's Jim Cramer and the 'Squawk on the Street' team discuss a new report that Horizon Therapeutics is in preliminary talks with major pharmaceutical companies over a potential takeover.
3 Top Dividend Kings to Buy for the Long Haul
08:05am, Wednesday, 30'th Nov 2022
Dividend stocks are an easy option to boost income.
Eleven Stocks Turned $10,000 To $261,421 In 11 Months
08:00am, Wednesday, 30'th Nov 2022
Most S&P 500 investors got a little gain this month. But investors willing to look off the beaten path found huge gains.
Horizon Therapeutics Rockets As It Considers Potential Bids From Amgen, J&J, Sanofi
05:38pm, Tuesday, 29'th Nov 2022
Horizon said Tuesday it's considering potential offers from three Big Pharma stalwarts, sending HZNP stock soaring more than 30% after hours. The post Horizon Therapeutics Rockets As It Considers Pote
